Last deal

$4.2M

Amount

Series A

Stage

18.11.2019

Date

4

all rounds

$5.2M

Total amount

General

About Company
Winterlight Labs uses artificial intelligence technology to detect and monitor cognitive and mental diseases.

Industry

Sector :

Subsector :

Also Known As

Winterlight

founded date

01.01.2015

Number of employees

Company Type

For Profit

Last funding type

Series A

IPO status

Private

Description

Their language-based diagnostic system uses machine learning and AI to analyze and quantify aspects of speech and language for tracking cognition and disease progression, providing early detection of cognitive impairment. With over 47.5 million individuals in the world with dementia, Winterlight's technology can detect Alzheimer's Disease with 82% accuracy and aphasia with 100% accuracy, using just a short 1-5 minute snippet of speech. Their team has years of experience and actively publishes in computer science and neuroscience journals and conferences.
Contacts